Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.

Autor: Stemmer, S M, Hardan, I, Raz, H, Adamou, A K, Inbar, M, Gottfried, M, Merrick, Y, Cohen, Y, Sulkes, A, Ben-Baruch, N, Pfeffer, R P, Brenner, H J, Rizel, S
Zdroj: Bone Marrow Transplantation. Apr2003, Vol. 31 Issue 8, p655. 7p.
Databáze: Academic Search Ultimate